A research team at the University of Barcelona's Institute of Neurosciences (UBneuro) has discovered new molecular mechanisms related to the cognitive decline associated with Alzheimer's disease, the ...

Spread the loveIn a groundbreaking study, researchers at the Washington University School of Medicine have unveiled a novel approach to combat Alzheimer’s disease using a method they have termed ...

The link between Alzheimer’s disease and amyloid plaques is well documented, with innumerable studies exploring techniques and therapies to inhibit plaque formation, preventing development or ...

Researchers at Baylor College of Medicine have discovered a natural mechanism that clears existing amyloid plaques in the brains of mouse models of Alzheimer's disease and preserves cognitive function ...

Scientists have developed a promising new approach to treating Alzheimer’s disease by turning ordinary brain cells into powerful plaque-clearing machines. Instead of requiring frequent antibody ...

For many years, astrocytes were seen as simple support cells in the brain. Today, that picture is changing fast. These star-shaped brain cells do more than provide structural help—they actively shape ...

Researchers from the NeuroAD group (Neuropathology of Alzheimer's Disease) within the Department of Cell Biology, Genetics and Physiology at the University of Málaga, also affiliated with ...

Researchers discovered that raising the protein Sox9 can help the brain’s astrocytes clear out toxic plaque buildup linked to Alzheimer’s. In mouse models that already showed memory problems, ...

For all the reams of previous research on APOE, scientists are still turning up fresh insights on how its alleles affect biology and disease risk. At the 18th Clinical Trials on Alzheimer’s Disease ...

The new generation of Alzheimer's disease drugs - the first proven to change the course of the disease - typically extend independent living for patients by 10 months. Called monoclonal antibodies, ...

The new generation of Alzheimer’s disease drugs — the first proven to change the course of the disease — typically extend independent living for patients by 10 months. Called monoclonal antibodies, ...

A new study found that treatment with an immunotherapy cancer drug restored cognitive function in an Alzheimer’s mouse model. Zhang Peng/LightRocket via Getty Images It has long been understood that ...